PRKN and hepatocellular carcinoma: In addition, GLI1 editing promotes a metabolic shift to oxidative phosphorylation to sustain stemness through PINK1/Parkin-mediated mitophagy in hepatocellular carcinoma (HCC), therefore enhancing metastatic potential and sorafenib resistance of HCC.